Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel temperature-sensitive liposomes with prolonged circulation time.

Lars H Lindner1, Martin E Eichhorn, Hansjoerg Eibl

  • 1Department of Internal Medicine III, Klinikum Grosshadern Medical Center (KGMC), Ludwig-Maximilians-University, Munich, Germany. Lars.Lindner@med.uni-muenchen.de

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|March 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Oncology and therapy·2026
Same author

Pulmonary Actinomycosis: A Hidden Threat with Clinical Impact.

Advances in respiratory medicine·2026
Same author

Response to Letter to the Editor: Comments on "Surgery for Retroperitoneal Soft Tissue is Safe following Multimodal Treatment with Regional Hyperthermia".

Annals of surgical oncology·2026
Same author

Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial.

Cancer·2026
Same author

Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II Trial.

International journal of cancer·2026
Same author

Transthoracic robot-assisted minimally invasive diaphragmatic rupture repair: a case report.

Journal of medical case reports·2026
Same journal

Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Claudin 18.2 Targeting: A Pan-Cancer Perspective.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
See all related articles

New temperature-sensitive liposomes enhance chemotherapy by releasing drugs specifically in heated tumors. This novel formulation improves drug delivery and circulation time for cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Drug Delivery Systems
  • Oncology

Background:

  • Hyperthermia enhances chemotherapy efficacy in cancer treatment.
  • Temperature-sensitive liposomes can improve drug release at tumor sites.
  • Mild hyperthermia (41-42°C) is a promising adjunct therapy.

Purpose of the Study:

  • To develop novel temperature-sensitive liposomes for enhanced drug delivery in cancer therapy.
  • To evaluate the properties of liposomes containing 1.2-dipalmitoyl-sn-glycero-3-phosphoglyceroglycerol (DPPGOG) under mild hyperthermia.
  • To assess the in vivo performance of these liposomes regarding drug release, circulation time, and tissue accumulation.

Main Methods:

  • Formulation of temperature-sensitive liposomes using DPPGOG, 1.2-dipalmitoyl-sn-glycero-3-phosphocholine, and 1.2-distearoyl-sn-glycero-3-phosphocholine.

Related Experiment Videos

  • Characterization of liposome properties, including diameter (175 nm) and drug release kinetics.
  • In vivo studies in hamsters and rats to determine plasma half-life and tissue drug accumulation using quantitative fluorescence microscopy.

    • Main Results:

    • DPPGOG-based liposomes exhibited favorable properties under mild hyperthermia (41-42°C).
    • Liposomes demonstrated temperature-triggered drug release and prolonged plasma half-life (9.6h in hamsters, 5.0h in rats).
    • Significant increase (over sixfold) in tumor tissue drug concentration was observed compared to non-liposomal delivery.

    Conclusions:

    • A novel DPPGOG-based liposomal formulation offers long circulation time and efficient drug release under mild hyperthermia.
    • These liposomes improve drug accumulation in heated tumor tissue.
    • This technology expands therapeutic options for cancer treatment when combined with hyperthermia.